[go: up one dir, main page]

AU2001240563A1 - Detection of differential gene expression - Google Patents

Detection of differential gene expression

Info

Publication number
AU2001240563A1
AU2001240563A1 AU2001240563A AU4056301A AU2001240563A1 AU 2001240563 A1 AU2001240563 A1 AU 2001240563A1 AU 2001240563 A AU2001240563 A AU 2001240563A AU 4056301 A AU4056301 A AU 4056301A AU 2001240563 A1 AU2001240563 A1 AU 2001240563A1
Authority
AU
Australia
Prior art keywords
detection
gene expression
differential gene
differential
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001240563A
Inventor
Martin Grips
Martin Hellriegel
Bernd Hinzmann
Andre Rosenthal
Reinhold Schafer
Anne-Chantal Schmitz
Christine Sers
Oleg Tchernitsa
Johannes Zuber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metagen Pharmaceuticals GmbH
Original Assignee
METAGEN GES fur GENOMFORSCHUNG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by METAGEN GES fur GENOMFORSCHUNG filed Critical METAGEN GES fur GENOMFORSCHUNG
Publication of AU2001240563A1 publication Critical patent/AU2001240563A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2001240563A 2000-01-31 2001-01-31 Detection of differential gene expression Abandoned AU2001240563A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10004102A DE10004102A1 (en) 2000-01-31 2000-01-31 Nucleic acids differentially expressed between tumor and normal cells, useful for diagnosis or therapy of tumors and for screening active agents
DE10004102.7 2000-01-31
PCT/EP2001/001003 WO2001057058A2 (en) 2000-01-31 2001-01-31 Detection of differential gene expression

Publications (1)

Publication Number Publication Date
AU2001240563A1 true AU2001240563A1 (en) 2001-08-14

Family

ID=7629295

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001240563A Abandoned AU2001240563A1 (en) 2000-01-31 2001-01-31 Detection of differential gene expression

Country Status (5)

Country Link
US (1) US20030170625A1 (en)
EP (1) EP1303531A2 (en)
AU (1) AU2001240563A1 (en)
DE (1) DE10004102A1 (en)
WO (1) WO2001057058A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6759515B1 (en) 1997-02-25 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6482932B1 (en) * 1997-11-05 2002-11-19 Ribozyme Pharmaceuticals, Incorporated Nucleoside triphosphates and their incorporation into oligonucleotides
US6528640B1 (en) * 1997-11-05 2003-03-04 Ribozyme Pharmaceuticals, Incorporated Synthetic ribonucleic acids with RNAse activity
US6617438B1 (en) * 1997-11-05 2003-09-09 Sirna Therapeutics, Inc. Oligoribonucleotides with enzymatic activity
EP1961818A3 (en) 1999-04-09 2008-09-10 Chugai Seiyaku Kabushiki Kaisha Novel fetal genes
AU2001245953A1 (en) * 2000-03-24 2001-10-08 Genzyme Corporation Oncogenic osteomalacia-related gene 1
US20060063230A1 (en) 2000-12-27 2006-03-23 Roman Naworth Sulfatases and methods of use thereof
AU2002318112B2 (en) 2001-04-10 2007-12-06 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
US20050069877A1 (en) * 2001-06-22 2005-03-31 Gandhi Ameena R. Protein modification and maintenance molecules
DE10158517A1 (en) * 2001-11-29 2003-06-12 Focusgenomics Gmbh Procedure for the analysis of translation-controlled gene expression
FR2853909A1 (en) * 2003-04-16 2004-10-22 Galderma Res & Dev Using polynucleotide probes based on the DPYSL3 gene (Dihydropyrimidinase-like 3), for diagnosis of psoriasis, or predisposition, and in screening for antipsoriatic agents
JP4643450B2 (en) 2003-08-08 2011-03-02 株式会社ペルセウスプロテオミクス Cancer high expression gene
AU2004278779A1 (en) * 2003-10-06 2005-04-14 Centocor, Inc. Hypoxia - responsive human CNGH-0002 genes and polypeptides
US7563885B1 (en) 2004-05-24 2009-07-21 Isis Pharmaceuticals, Inc. Modulation of Tudor-SN expression
CA2622295C (en) 2005-09-12 2019-01-15 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
US9957569B2 (en) 2005-09-12 2018-05-01 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
AU2008275303B2 (en) * 2007-07-06 2012-05-03 The Regents Of The University Of Michigan MIPOL1-ETV1 gene rearrangements
US8106037B2 (en) 2007-08-03 2012-01-31 The Brigham And Women's Hospital, Inc. Identification and treatment of estrogen responsive prostate tumors
WO2011034906A2 (en) 2009-09-17 2011-03-24 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
US8945556B2 (en) 2010-11-19 2015-02-03 The Regents Of The University Of Michigan RAF gene fusions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612215A (en) * 1992-12-07 1997-03-18 Ribozyme Pharmaceuticals, Inc. Stromelysin targeted ribozymes
US5643761A (en) * 1993-10-27 1997-07-01 The Trustees Of Columbia University In The City Of New York Method for generating a subtracted cDNA library and uses of the generated library
US5837815A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polypeptide products
US6204001B1 (en) * 1995-11-24 2001-03-20 The Trustees Of Columbia University In The City Of New York Methods for determining compounds capable of inhibiting the activities of the Ha-Ras oncongene
JP2002500010A (en) * 1997-12-23 2002-01-08 カイロン コーポレイション Human Genes and Gene Expression Products I
US6004755A (en) * 1998-04-07 1999-12-21 Incyte Pharmaceuticals, Inc. Quantitative microarray hybridizaton assays
US5948680A (en) * 1998-12-17 1999-09-07 Isis Pharmaceuticals Inc. Antisense inhibition of Elk-1 expression

Also Published As

Publication number Publication date
US20030170625A1 (en) 2003-09-11
WO2001057058A2 (en) 2001-08-09
EP1303531A2 (en) 2003-04-23
WO2001057058A3 (en) 2003-02-13
DE10004102A1 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
AU2001240563A1 (en) Detection of differential gene expression
AU4640400A (en) Analysis of differential protein expression
AU2001288762A1 (en) Detection and characterization of microorganisms
AU2001234608A1 (en) Methods for analysis of gene expression
AU2001293336A1 (en) Nucleic acid detection medium
AU2001245499A1 (en) Limited slip differential
AU2001234880A1 (en) Mapping of differential display of proteins
AU2002357714A1 (en) Sensors and methods of detection for proteinase enzymes
AU2002214126A1 (en) Genetic analysis of microorganisms
AU2001267428A1 (en) Direct detection of individual molecules
AU2002213164A1 (en) Detection of dna damage
AU2001250428A1 (en) Genes of the 1-desoxy-d-xylulose biosynthesis path
AU2001229530A1 (en) Detection of fermentation-related microorganisms
AU2928400A (en) Analysis of differential gene expression
AU5412600A (en) Detection of microorganisms
AU2001264247A1 (en) GASC1 gene
AU2002321899A1 (en) Detection of differential expression of protein using gel-free proteomics
AU2001251004A1 (en) Detection of viable agents
AU2001247444A1 (en) Erbeta-mediated gene expression
AU2002221104A1 (en) Method of detecting relation between genes
EP1165825A4 (en) Toxicant-induced differential gene expression
AU2001271172A1 (en) Interpretation of visual information
AU2002324232A1 (en) Differential gene expression in schizophrenia
AU2001292922A1 (en) Nucleic acid detection
AU2001251245A1 (en) Haplotypes of the apoa4 gene